Record #61570
Rosiglitazone and 15-deoxy-Δ12,14-prostaglandin J2, ligands of the peroxisome proliferator-activated receptor-γ (PPAR-γ), reduce ischaemia/reperfusion injury of the gut
Publisher
Original paper date
Feb 2, 2009
Original DOI
Country
Institution
Department of Clinical and Experimental Medicine and Pharmacology, Torre Biologica, Policlinico Universitario, 98123 Messina, Italy · Department of Experimental Pharmacology, University of Naples Federico II, Italy · Department of Experimental Medicine & Nephrology, The William Harvey Research Institute, St Bartholomew’s and The Royal London School of Medicine and Dentistry, Charterhouse Square, London EC1M 6BQ
Open access
No
Article type
Broad categories
Notes from Retraction Watch
see also: https://pubpeer.com/publications/A0E8C439DA8DDEF1CE30EAFDE38931
Citation lifecycle
How this paper is being cited
Pre-retraction
94
Same day
0
Post-retraction
0
% post-retraction
0.0%
~5.9 citations/yr before retraction · ~0.0 citations/yr after
— citing papers
Who is still citing this work
Loading…